Herbal Combinational Medication of Glycyrrhiza glabra, Agastache rugosa Containing Glycyrrhizic Acid, Tilianin Inhibits Neutrophilic Lung Inflammation by Affecting CXCL2, Interleukin-17/STAT3 Signal Pathways in a Murine Model of COPD

Autor: Jung-Hee Hong, Jeong-Ho Geum, Hye-Rim Kim, Won-Kyung Yang, Seung-Hyung Kim, Yun-Mi Kang, Su-Young Choi, Hyo-Jin An, Young-Cheol Lee
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
Chronic bronchitis
Agastacha rugosa
Agastache
Chemokine CXCL2
Pharmacology
Polymerase Chain Reaction
STAT3
Mice
Pulmonary Disease
Chronic Obstructive

0302 clinical medicine
Glycosides
Lung
Mice
Inbred BALB C

Nutrition and Dietetics
biology
medicine.diagnostic_test
Chemistry
Interleukin-17
respiratory system
CXCL-2
CXCL2
IL-17
030220 oncology & carcinogenesis
Interleukin 17
lcsh:Nutrition. Foods and food supply
Signal Transduction
STAT3 Transcription Factor
Glycyrrhiza glabra
lcsh:TX341-641
Lung injury
complex mixtures
Article
Proinflammatory cytokine
03 medical and health sciences
medicine
Glycyrrhiza
Animals
COPD
Flavonoids
Plant Extracts
Pneumonia
biology.organism_classification
Glycyrrhizic Acid
Agastache rugosa
respiratory tract diseases
Disease Models
Animal

030104 developmental biology
Bronchoalveolar lavage
Food Science
Zdroj: Nutrients
Volume 12
Issue 4
Nutrients, Vol 12, Iss 926, p 926 (2020)
ISSN: 2072-6643
DOI: 10.3390/nu12040926
Popis: Chronic obstructive pulmonary disease (COPD) is caused by exposure to toxic particles, such as coal fly ash (CFA), diesel-exhaust particle (DEP), and cigarette smoke (CS), leading to chronic bronchitis, mucus production, and a subsequent lung dysfunction. This study, using a mouse model of COPD, aimed to evaluate the effect of herbal combinational medication of Glycyrrhiza glabra (GG), Agastache rugosa (AR) containing glycyrrhizic acid (GA), and tilianin (TN) as active ingredients. GA, a major active component of GG, possesses a range of pharmacological and biological activities including anti-inflammatory, anti-allergic, anti-oxidative. TN is a major flavonoid that is present in AR. It has been reported to have anti-inflammatory effects of potential utility as an anti-COPD agent. The COPD in the mice model was induced by a challenge with CFA and DEP. BALB/c mice received CFA and DEP alternately three times for 2 weeks to induce COPD. The herbal mixture of GG, AR, and TN significantly decreased the number of neutrophils in the lungs and bronchoalveolar lavage (BAL) fluid. It also significantly reduced the production of C-X-C motif chemokine ligand 2 (CXCL-2), IL-17A, CXCL-1, TNF-&alpha
symmetric dimethylarginine (SDMA) in BALF and CXCL-2, IL-17A, CXCL-1, MUC5AC, transient receptor potential vanilloid-1 (TRPV1), IL-6, COX-2, NOS-II, and TNF-&alpha
mRNA expression in the lung tissue. Notably, a combination of GG and AR was more effective at regulating such therapeutic targets than GG or AR alone. The histolopathological lung injury was alleviated by treatment with the herbal mixture and their active ingredients (especially TN). In this study, the herbal combinational mixture more effectively inhibited neutrophilic airway inflammation by regulating the expression of inflammatory cytokines and CXCL-2 by blocking the IL-17/STAT3 pathway. Therefore, a herbal mixture of GG and AR may be a potential therapeutic agent to treat COPD.
Databáze: OpenAIRE